Literature DB >> 14510247

Prediction model to identify patients with Staphylococcus aureus bacteremia at risk for methicillin resistance.

Thomas P Lodise1, Peggy S McKinnon, Michael Rybak.   

Abstract

OBJECTIVES: To identify institution-specific risk factors for MRSA bacteremia and develop an objective mechanism to estimate the probability of methicillin resistance in a given patient with Staphylococcus aureus bacteremia (SAB).
DESIGN: A cohort study was performed to identify institution-specific risk factors for MRSA. Logistic regression was used to model the likelihood of MRSA. A stepwise approach was employed to derive a parsimonious model. The MRSA prediction tool was developed from the final model.
SETTING: A 279-bed, level 1 trauma center. PATIENTS: Between January 1, 1999, and June 30, 2001, 494 patients with clinically significant episodes of SAB were identified.
RESULTS: The MRSA rate was 45.5%. Of 18 characteristics included in the logistic regression, the only independent features for MRSA were prior antibiotic exposure (OR, 9.2; CI95, 4.8 to 17.9), hospital onset (OR, 3.0; CI95, 1.9 to 4.9), history of hospitalization (OR, 2.5; CI95, 1.5 to 3.8), and presence of decubitus ulcers (OR, 2.5; CI95, 1.2 to 4.9). The prediction tool was derived from the final model, which was shown to accurately reflect the actual MRSA distribution in the cohort.
CONCLUSION: Through multivariate modeling techniques, we were able to identify the most important determinants of MRSA at our institution and develop a tool to predict the probability of methicillin resistance in a patient with SAB. This knowledge can be used to guide empiric antibiotic selection. In the era of antibiotic resistance, such tools are essential to prevent indiscriminate antibiotic use and preserve the longevity of current antimicrobials.

Entities:  

Mesh:

Year:  2003        PMID: 14510247     DOI: 10.1086/502269

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  12 in total

1.  MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003.

Authors:  David H Wyllie; Tim E A Peto; Derrick Crook
Journal:  BMJ       Date:  2005-09-09

2.  Refining vancomycin protein binding estimates: identification of clinical factors that influence protein binding.

Authors:  Jill M Butterfield; Nimish Patel; Manjunath P Pai; Thomas G Rosano; George L Drusano; Thomas P Lodise
Journal:  Antimicrob Agents Chemother       Date:  2011-06-13       Impact factor: 5.191

3.  Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.

Authors:  Kerry L LaPlante; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

4.  Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance.

Authors:  Thomas P Lodise; Christopher D Miller; Jeffrey Graves; Jon P Furuno; Jessina C McGregor; Ben Lomaestro; Eileen Graffunder; Louise-Anne McNutt
Journal:  Antimicrob Agents Chemother       Date:  2006-12-11       Impact factor: 5.191

5.  Trends in nosocomial bloodstream infections in a burn intensive care unit: an eight-year survey.

Authors:  A Zorgani; R A Franka; M M Zaidi; U M Alshweref; M Elgmati
Journal:  Ann Burns Fire Disasters       Date:  2010-06-30

6.  Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.

Authors:  John Weigelt; Kamal Itani; Dennis Stevens; William Lau; Matthew Dryden; Charles Knirsch
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

7.  In vitro pharmacodynamics of human simulated exposures of ceftaroline and daptomycin against MRSA, hVISA, and VISA with and without prior vancomycin exposure.

Authors:  Amira A Bhalodi; Mao Hagihara; David P Nicolau; Joseph L Kuti
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

8.  Molecular epidemiology of hospital-onset methicillin-resistant Staphylococcus aureus infections in Southern Chile.

Authors:  G Medina; A L Egea; C Otth; L Otth; H Fernández; J L Bocco; M Wilson; C Sola
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-06-14       Impact factor: 3.267

9.  Risk factors for methicillin-resistant Staphylococcus aureus bacteraemia differ depending on the control group chosen.

Authors:  M Pogorzelska-Maziarz; E Y Furuya; E L Larson
Journal:  Epidemiol Infect       Date:  2013-02-21       Impact factor: 4.434

10.  Community strains of methicillin-resistant Staphylococcus aureus as potential cause of healthcare-associated infections, Uruguay, 2002-2004.

Authors:  Stephen R Benoit; Concepción Estivariz; Cristina Mogdasy; Walter Pedreira; Antonio Galiana; Alvaro Galiana; Homero Bagnulo; Rachel Gorwitz; Gregory E Fosheim; Linda K McDougal; Daniel Jernigan
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.